Unlearn AI: Difference between revisions
Created from AIDAVA Related Companies research |
Added business details: founded 2019, funding $50M Series C |
||
| Line 17: | Line 17: | ||
'''Valuation:''' ~$200M+ (est.) | '''Valuation:''' ~$200M+ (est.) | ||
$50M+ | $50M+ | ||
== Business Details == | |||
* '''Founded:''' 2019 | |||
* '''Total Funding:''' $50M Series C | |||
* '''Valuation:''' ~$200M+ (est.) | |||
* '''Revenue:''' N/A (private) | |||
* '''Employees:''' ~50-100 (est.) | |||
* '''Key Milestones:''' $50M Series C. Digital twins for clinical trials. Applied to VectorY PIONEER-ALS study. | |||
== See Also == | == See Also == | ||
Revision as of 15:53, 14 April 2026
What They Do
Generates AI digital twins from clinical data to optimize clinical trials. Uses patient longitudinal data for prediction and generates synthetic control arms, reducing trial sizes and timelines.
AIDAVA Relevance
Longitudinal patient data for digital twins, synthetic data generation
Funding
Valuation: ~$200M+ (est.) $50M+
Business Details
- Founded: 2019
- Total Funding: $50M Series C
- Valuation: ~$200M+ (est.)
- Revenue: N/A (private)
- Employees: ~50-100 (est.)
- Key Milestones: $50M Series C. Digital twins for clinical trials. Applied to VectorY PIONEER-ALS study.